The Coleman Institute

The Coleman Institute provides specialized outpatient detoxification services for individuals struggling with opioid and alcohol addiction, focusing on effective and accessible recovery solutions. Founded in 1998, The Coleman Institute is based in Richmond, US, offering detox programs tailored to individual needs. The company has not undergone any notable pivots or structural changes since its inception. In February 2017, BayMark Health Services Inc.

acquired The Coleman Institute for an undisclosed sum, marking a strategic enhancement in its operations. The Coleman Institute specializes in outpatient detoxification services for individuals seeking recovery from opioid and alcohol addiction. Its primary offerings include tailored detox programs designed to minimize withdrawal symptoms, allowing patients to complete the detox process in as little as three days, with a reported completion rate of 98%. The services address a variety of substance dependencies, including opioids such as heroin, fentanyl, and prescription pain medications, as well as alcohol and benzodiazepines.

The company caters to a diverse client base that includes self-pay patients and those using insurance plans, such as Anthem Blue Cross Blue Shield and Sentara. The Coleman Institute operates in multiple geographic markets across the United States, with locations in cities including Atlanta, Denver, Richmond, San Francisco, and Tampa, thereby serving a nationwide clientele seeking effective and accessible detox solutions. The Coleman Institute generates revenue primarily through its outpatient detox programs, charging patients for treatment services. The transactional structure involves direct-to-consumer interactions, where clients pay for their detox therapy, which may include additional recommended services such as 12 months of Naltrexone therapy for long-term recovery support.

Pricing is structured around the detox program duration, typically ranging from three to eight days, depending on individual patient needs. The firm's ability to accept various insurance plans broadens its customer base, ensuring that a wider range of patients can access its services. In the coming years, The Coleman Institute aims to expand its service offerings by developing new detox programs targeting specific substance use challenges. Additionally, the company plans to extend its geographic reach into new markets, focusing on areas with high demand for detox services.

The acquisition by BayMark Health Services Inc. in February 2017 will support these initiatives by providing the necessary resources for expansion and development.